Form D · Other Technology
Proviera Biotech, LLC
Kansas City, MO · CIK 0001601173
Offering snapshot reported Mar 6, 2014 · SEC filing
- Reported sold
- $1M Offering amount: $2M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 18, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 6, 2014 | Initial | $1,004,546 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-213005
Source: Form D, filed Mar 6, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Matthew Wood | Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
1627 Main Street Ste 700
Kansas City, MO, 64108
Kansas City, MO, 64108